Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-037134
Filing Date
2023-07-31
Accepted
2023-07-31 21:35:42
Documents
1
Period of Report
2023-07-27

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 8112
  Complete submission text file 0001140361-23-037134.txt   9473
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UOVANT SCIENCES, INC. 5151 CALIFORNIA AVENUE, SUITE 250 IRVINE CA 92617
Business Address
Sukhatme Mayukh (Reporting) CIK: 0001750050 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40782 | Film No.: 231129319